High-dose alkylating agent chemotherapy with autologous bone marrow support in patients with stage III/IV epithelial ovarian cancer.
Journal Article (Clinical Trial;Journal Article)
Full Text
Duke Authors
Cited Authors
- Shpall, EJ; Clarke-Pearson, D; Soper, JT; Berchuck, A; Jones, RB; Bast, RC; Ross, M; Lidor, Y; Vanacek, K; Tyler, T
Published Date
- September 1990
Published In
Volume / Issue
- 38 / 3
Start / End Page
- 386 - 391
PubMed ID
- 2121627
International Standard Serial Number (ISSN)
- 0090-8258
Digital Object Identifier (DOI)
- 10.1016/0090-8258(90)90079-z
Language
- eng
Conference Location
- United States